The Fourth People's Hospital of Qinghai Province
7
1
1
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
14%
1 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Noninvasive Diagnosis Model for High-risk Varices in Cirrhosis
Role: collaborator
Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106)
Role: collaborator
Observational Clinical Study of the Natural Course and Long-term Prognosis of Patients With Chronic Liver Disease
Role: collaborator
Baveno VI Criteria in Dynamic Monitoring of High-risk Varices in Compensated Cirrhotic Patients
Role: collaborator
Safety and Immunogenicity of COVID-19 Vaccine Booster in Patients With Liver Diseases
Role: collaborator
A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B
Role: collaborator
Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis
Role: collaborator
All 7 trials loaded